Related factor analysis and management of failed tumor prosthesis in the distal femur

Jian-ping HU,Kun-peng ZHU,Chun-lin ZHANG
DOI: https://doi.org/10.3969/j.issn.2095-252X.2017.06.004
2017-01-01
Abstract:Objective To investigate the non-recurrent factors and management of the failed tumor prosthesis reconstructed for the bone defect in the distal femur. Methods A retrospective analysis was performed on 78 patients with bone tumors in the distal femur from January 2006 to December 2013, and the diagnoses were pathologically confirmed, including 58 patients with osteosarcoma, 16 with giant cell sarcoma and 4 others. Limb salvage procedure with custom cemented prosthesis was chosen as the primary surgery strategy. We analyzed the factors of failure during the follow-up, reoperation was performed on the patients with failed prostheses after complications of deep infection, aseptic loosening and mechanical obstruction. Results Until the end of follow-up, 13 complications occurred, including 6 patients with aseptic loosening, 3 with deep infection, 3 with poor wound healing and 1 with dislocated component of prosthesis. There were 9 males and 4 females, whose average age was 25.6 years ( range: 16 - 37 years ) when complications occurred. There were 10 failed prostheses until the end of follow-up, and the expected 5-year survival rate was 81.4%. Through analyzing the risky factors that might result in aseptic loosening, we found that higher body mass index ( BMI ) in the patients whose joint function got recovered at 2 months after primary prosthesis replacement and lager bone defect after tumor resection especially when bone defect > 40% were independent risky factors of aseptic loosening which could result in prosthesis failure. The mean age of the 6 patients with aseptic loosening was 27.1 years. More athletic younger patients ( < 40 years ) were prone to incur the incidence of aseptic loosening ( P = 0.197 ). Deep infection happened to 3 patients within the first month after primary surgery, of whom, 2 patients received second-stage revision after removing the prosthesis and 1 patient accepted amputation. The patient with dislocated component at the second month after surgery received open reduction immediately. Six patients with aseptic loosening underwent revision with new custom cemented prosthesis with additional stem length ( average:5.2 cm, range: 4 - 6 cm ) and wider diameter. The average follow-up from the primary operation to the incidence of complications was 45 months ( range: 28 - 75 months ). The average MSTS score raised from 14.3 ( range: 12 -17 ) before revision to 28.5 ( range: 27 - 30 ) after an average follow-up of 34.3 months ( range: 18 - 58 months ). No incidence of complications was recorded after reoperation. Conclusions Aseptic loosening is the major non-recurrent factor of the failed tumor prosthesis in the distal femur and satisfactory outcomes can be gained after revision with new custom cemented prosthesis with longer stem length and wider diameter.
What problem does this paper attempt to address?